**Qualitek Labs IPO: Navigating Growth in Testing and Inspection Services**
Qualitek Labs Limited is set to launch its Initial Public Offering (IPO) to raise funds for strategic initiatives. The fixed-price issue amounts to Rs 19.64 crores, exclusively through a fresh issue of 19.64 lakh shares. Let’s delve into the comprehensive details of the Qualitek Labs IPO:
**Key Details of Qualitek Labs IPO:**
– **IPO Dates:** January 18, 2024, to January 22, 2024
– **Price:** ₹100 per share
– **Lot Size:** 1200 Shares
– **Total Issue Size:** 1,964,400 shares (aggregating up to ₹19.64 Cr)
– **Fresh Issue:** 1,964,400 shares (aggregating up to ₹19.64 Cr)
– **Issue Type:** Fixed Price Issue IPO
– **Listing Venue:** BSE SME
– **Listing Date:** Tentatively set for Thursday, January 25, 2024
**Reservation Breakdown:**
– **NII:** 932,400 shares (47.46%)
– **RII (Retail):** 932,400 shares (47.46%)
– **Market Maker:** 99,600 shares (5.07%)
– **Total:** 1,964,400 shares (100%)
**Qualitek Labs IPO Timeline:**
– **IPO Opens:** January 18, 2024
– **IPO Closes:** January 22, 2024
– **Basis of Allotment:** January 23, 2024
– **Refund Initiation:** January 24, 2024
– **Credit of Shares to Demat:** January 24, 2024
– **Listing Date:** January 25, 2024
– **Cut-off time for UPI mandate confirmation:** 5 PM on January 22, 2024
**Qualitek Labs IPO Lot Size:**
Investors can bid for a minimum of 1200 shares and in multiples thereof.
**Promoter Holding:**
Alok Kumar Agarwal, Antaryami Nayak, Kamal Grover, and TIC Services Private Limited are the promoters, holding 99.99% pre-issue and 73.35% post-issue.
**About Qualitek Labs Limited:**
Founded in 2018, Qualitek Labs is a provider of testing, inspection, homologation, certification, and consulting services. The company operates in various segments, including Automotive Testing, Defence Product Testing, Metals & Metallurgy Testing, Mineral Testing, Environment & Water Testing, Food and Agriculture Testing, Pharma & Healthcare.
With testing laboratories in Pune and Bhubaneshwar, the company has positioned itself as a prominent player in the industry.
**Financial Performance:**
Qualitek Labs demonstrated robust financial growth, with revenue increasing by 61.03%, and profit after tax (PAT) rising by 161.43% between the financial years ending March 31, 2023, and March 31, 2022.
**Key Performance Indicators:**
– **ROE:** 50.49%
– **ROCE:** 13.76%
– **RoNW:** 30.10%
– **P/BV:** 4.04
**IPO Objectives:**
The net proceeds from the issue will be allocated towards:
– Funding capital expenditure for new & existing laboratories
– Repayment of unsecured loans to Promoters
– Funding working capital requirements
– General corporate purposes
**Subscription Status on Day 1**
As of January 18, 2024, 10:50 AM (Day 1), the Qualitek Labs IPO has achieved a subscription rate of 0.35 times. In the breakdown of categories:
– The Non-Institutional Investors (NII) category is subscribed 0.06 times, with 51,600 shares bid for out of 9,32,400 shares offered.
– The Retail category exhibits a subscription of 0.64 times, where 5,92,800 shares have been bid for out of 9,32,400 shares offered.
– The overall subscription, encompassing all categories, stands at 0.35 times, with a total of 6,44,400 shares bid for out of 18,64,800 shares offered.
The total number of applications received is 569. Please note that these figures may evolve as the subscription period progresses.
**Conclusion:**
Qualitek Labs IPO offers investors an opportunity to participate in a company providing essential services in the testing and inspection domain. The IPO’s proceeds are geared towards strategic expansion and strengthening the company’s financial position. However, investors should carefully consider the details and conduct their due diligence before making investment decisions.
